van Keulen Danielle, van Koeverden Ian D, Boltjes Arjan, Princen Hans M G, van Gool Alain J, de Borst Gert J, Asselbergs Folkert W, Tempel Dennie, Pasterkamp Gerard, van der Laan Sander W
Laboratory of Experimental Cardiology, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands.
Central Diagnostics Laboratory, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands.
Front Cardiovasc Med. 2021 Apr 20;8:658915. doi: 10.3389/fcvm.2021.658915. eCollection 2021.
Oncostatin M (OSM) signaling is implicated in atherosclerosis, however the mechanism remains unclear. We investigated the impact of common genetic variants in and its receptors, and , on overall plaque vulnerability, plaque phenotype, intraplaque and expression, coronary artery calcification burden and cardiovascular disease susceptibility. We queried Genotype-Tissue Expression data and found that rs13168867 (C allele) was associated with decreased expression and that rs10491509 (A allele) was associated with increased expression in arterial tissues. No variant was significantly associated with expression. We associated these two variants with plaque characteristics from 1,443 genotyped carotid endarterectomy patients in the Athero-Express Biobank Study. After correction for multiple testing, rs13168867 was significantly associated with an increased overall plaque vulnerability (β = 0.118 ± s.e. = 0.040, = 3.00 × 10, C allele). Looking at individual plaque characteristics, rs13168867 showed strongest associations with intraplaque fat (β = 0.248 ± s.e. = 0.088, = 4.66 × 10, C allele) and collagen content (β = -0.259 ± s.e. = 0.095, = 6.22 × 10, C allele), but these associations were not significant after correction for multiple testing. rs13168867 was not associated with intraplaque expression. Neither was intraplaque expression associated with plaque vulnerability and no known eQTLs were associated with coronary artery calcification burden, or cardiovascular disease susceptibility. No associations were found for rs10491509 in the locus. Our study suggests that rs1316887 in the OSMR locus is associated with increased plaque vulnerability, but not with coronary calcification or cardiovascular disease risk. It remains unclear through which precise biological mechanisms OSM signaling exerts its effects on plaque morphology. However, the OSM-OSMR/LIFR pathway is unlikely to be causally involved in lifetime cardiovascular disease susceptibility.
抑瘤素M(OSM)信号传导与动脉粥样硬化有关,但其机制尚不清楚。我们研究了OSM及其受体(OSMR和LIFR)中常见基因变异对整体斑块易损性、斑块表型、斑块内OSM和LIFR表达、冠状动脉钙化负担以及心血管疾病易感性的影响。我们查询了基因型-组织表达数据,发现rs13168867(C等位基因)与动脉组织中OSM表达降低有关,而rs10491509(A等位基因)与LIFR表达增加有关。没有变异与OSMR表达显著相关。在动脉粥样硬化表达生物样本库研究中,我们将这两个变异与1443例接受基因分型的颈动脉内膜切除术患者的斑块特征进行了关联分析。在进行多重检验校正后,rs13168867与整体斑块易损性增加显著相关(β=0.118±标准误=0.040,P=3.00×10⁻³,C等位基因)。观察个体斑块特征时,rs13168867与斑块内脂肪(β=0.248±标准误=0.088,P=4.66×10⁻³,C等位基因)和胶原蛋白含量(β=-0.259±标准误=0.095,P=6.22×10⁻³,C等位基因)的关联最强,但在进行多重检验校正后,这些关联并不显著。rs13168867与斑块内OSM表达无关。斑块内LIFR表达与斑块易损性也无关,且没有已知的LIFR表达数量性状位点(eQTL)与冠状动脉钙化负担或心血管疾病易感性相关。在LIFR基因座中未发现rs10491509的关联。我们的研究表明,OSMR基因座中的rs1316887与斑块易损性增加有关,但与冠状动脉钙化或心血管疾病风险无关。目前尚不清楚OSM信号传导通过何种精确的生物学机制对斑块形态产生影响。然而,OSM-OSMR/LIFR途径不太可能因果性地参与终生心血管疾病易感性。